These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 25896164)
1. Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. Morales AM; Kohno M; Robertson CL; Dean AC; Mandelkern MA; London ED Mol Psychiatry; 2015 Jun; 20(6):764-71. PubMed ID: 25896164 [TBL] [Abstract][Full Text] [Related]
2. Midbrain dopamine D2/D3 receptor availability and drug craving are associated with mesocorticolimbic gray matter volume in methamphetamine users. Morales AM; Kohno M; Robertson CL; Dean AC; Mandelkern MA; London ED Mol Psychiatry; 2015 Jun; 20(6):658. PubMed ID: 25993553 [No Abstract] [Full Text] [Related]
3. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users. Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141 [TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence. Okita K; Petersen N; Robertson CL; Dean AC; Mandelkern MA; London ED Neuropsychopharmacology; 2016 Nov; 41(12):2913-2919. PubMed ID: 27329684 [TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300 [TBL] [Abstract][Full Text] [Related]
6. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users. Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927 [TBL] [Abstract][Full Text] [Related]
7. Nigrostriatal and Mesolimbic D Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278 [TBL] [Abstract][Full Text] [Related]
8. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment. Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310 [TBL] [Abstract][Full Text] [Related]
9. [ Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577 [TBL] [Abstract][Full Text] [Related]
10. Relationship between regional gray matter volumes and dopamine D Kurose S; Kubota M; Takahata K; Yamamoto Y; Fujiwara H; Kimura Y; Ito H; Takeuchi H; Mimura M; Suhara T; Higuchi M Hum Brain Mapp; 2021 Aug; 42(12):4048-4058. PubMed ID: 34014611 [TBL] [Abstract][Full Text] [Related]
11. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Okita K; Ghahremani DG; Payer DE; Robertson CL; Dean AC; Mandelkern MA; London ED Drug Alcohol Depend; 2016 Apr; 161():163-70. PubMed ID: 26880595 [TBL] [Abstract][Full Text] [Related]
13. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence. Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861 [TBL] [Abstract][Full Text] [Related]
14. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding. Zald DH; Woodward ND; Cowan RL; Riccardi P; Ansari MS; Baldwin RM; Cowan RL; Smith CE; Hakyemez H; Li R; Kessler RM Neuroimage; 2010 May; 51(1):53-62. PubMed ID: 20149883 [TBL] [Abstract][Full Text] [Related]
15. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users. Ballard ME; Dean AC; Mandelkern MA; London ED PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223 [TBL] [Abstract][Full Text] [Related]
16. The relationship between excitement symptom severity and extrastriatal dopamine D Joo YH; Kim JH; Son YD; Kim HK; Shin YJ; Lee SY; Kim JH Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):529-540. PubMed ID: 28623450 [TBL] [Abstract][Full Text] [Related]
17. Positive association between cerebral grey matter metabolism and dopamine D Mitelman SA; Buchsbaum MS; Christian BT; Merrill BM; Buchsbaum BR; Mukherjee J; Lehrer DS World J Biol Psychiatry; 2020 Jun; 21(5):368-382. PubMed ID: 31552783 [No Abstract] [Full Text] [Related]
18. Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy. Bernedo Paredes VE; Buchholz HG; Gartenschläger M; Breimhorst M; Schreckenberger M; Werhahn KJ PLoS One; 2015; 10(11):e0141098. PubMed ID: 26544593 [TBL] [Abstract][Full Text] [Related]
19. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: An [ Kim JH; Choe YS; Cumming P; Son YD; Kim HK; Joo YH; Kim JH Synapse; 2019 Nov; 73(11):e22121. PubMed ID: 31206840 [TBL] [Abstract][Full Text] [Related]